Sign inJoin waitlistJoin the waitlist

Tejas Patil

Associate Division Head for Clinical Affairs - Medical Oncology · University of Colorado School of Medicine

Credentials: · · · ·

History

University of Colorado School of Medicine
Present
University of Colorado School of Medicine
Present

University of Colorado School of Medicine
2018–2020
Internal Medicine
University of Colorado School of Medicine
2013–2016
Keck Sch of Med of the Univ of Southern Calif
2009–2013
University of Pennsylvania
2003–2007

Research

Acquired Resistance to KRASG12C Inhibition in Cancer
New England Journal of Medicine · 2021 · 1,038 citations
Non-Small Cell Lung Cancer, Version 4.2024, NCCN Clinical Practice Guidelines in Oncology
Journal of the National Comprehensive Cancer Network · 2024 · 922 citations
NCCN Guidelines® Insights: Non-Small Cell Lung Cancer, Version 2.2023
Journal of the National Comprehensive Cancer Network · 2023 · 469 citations

Ross Camidge
33 papers
Dara Aisner
25 papers
RD
Robert Doebele
13 papers
Jonathan Dowell
12 papers
Erin Schenk
11 papers
Jonathan Riess
11 papers
Paul Bunn
11 papers
Jessica Bauman
10 papers
Stephen Liu
10 papers
Aditi Singh
9 papers
Billy Loo
9 papers
Christine Lovly
9 papers

Clinical trials

CNS Dose Escalation/Expansion of Tepotinib in MET-driven NSCLC
Principal investigator · Terminated · Phase 1, Phase 2
Criterium, Inc.
2022–2023
Evaluating Crizotinib in the Neoadjuvant Setting in Patients With Non-small Cell Lung Cancer
Principal investigator · Completed · Phase 2
University of Colorado, Denver
2017–2021
Evaluating BL-M14D1 in Subjects With Locally Advanced or Metastatic Small Cell Lung Cancer and Neuroendocrine Tumors
Site PI · Recruiting · Phase 1
SystImmune Inc.
2025–2027
Targeted Treatment for Advanced Non-Small Cell Lung Cancer That Has a MET Exon 14 Skipping Gene Change (An Expanded Lung-MAP Treatment Trial)
Site PI · Recruiting · Phase 2
SWOG Cancer Research Network
2024–2028